Class II · Moderate risk
Neupogen (filgrastim)
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Is Filgrastim recalled?
Yes — there is an active recall. 3 ongoing FDA recalls mention Filgrastim (3 total). Check the affected lots below.
Most common reason: Stability / shelf life (3 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Filgrastim. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Filgrastim recalls in 2026
1 initiated in 2026, 3 in total — newest first
Class II · Moderate risk
Neupogen (filgrastim)
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Class II · Moderate risk
Granix (tbo-filgrastim)
Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.